Key Conclusions: The study concluded that the initial findings should be interpreted with caution and that further research is needed to confirm the association
FDA has also warned companies that have illegally sold unapproved drugs containing semaglutide, tirzepatide or retatrutide that are falsely labeled for research purposes or not for human consumption . These products have been sold directly to consumers for human use with dosing instructions
Its crucial to note that while these medications provide a significant advantage in weight management strategies, their maximum benefits are achieved and sustained through ongoing lifestyle changes, including healthy eating and physical activity
Regular monitoring and proper documentation of symptoms enable medical teams to make informed decisions about treatment plans
Personal stories vary: one person described needing new glasses because cheekbones showed more
These medications, produced are GLP-1 receptor agonists and contain the same active ingredient, semaglutide